Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer

Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer

BackgroundStereotactic body radiation therapy (SBRT) is used to manage lung metastases arising from colorectal cancer (CRC), but its effectiveness is constrained by the radioresistance of CRCs. Here, we explored whether concurrent therapy with cetuximab or bevacizumab could improve the prognosis of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiye Sun, Pei Shu, Yali Shen, Zhiping Li, Ning Liu, Ganlu Ouyang, Yuanling Tang, Meijuan Huang, Xin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
stereotactic body radiotherapy
colorectal carcinoma
oligometastatic lung tumors
cetuximab
bevacizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1464707/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items